Otolaryngology · 2019 · 16 citations · 18 references
MedicineImmunologyOncologyCancer ImmunologyMetastasisTumor MicroenvironmentLymph Node PathologyOral Cancer MetastasisOral Cavity CancerOropharyngeal CancerSquamous Cell CarcinomaTumor-associated MacrophagesCancer-associated MacrophagesDistant Metastatic SpreadMetastatic EvolutionMetastatic Squamous Cell CarcinomaOral Cavity PathologyOropharyngeal LesionsRecurrent Metastatic Disease
Objective The purpose of this study is to assess CD169 expression in metastatic and nearby tumor‐free lymph nodes of patients with head and neck squamous cell carcinoma (SCC). Study Design Retrospective analysis based on immunohistochemistry. Setting Tertiary care center. Subjects and Methods The abundance of CD169 + cells in the subcapsular sinuses (SCSs) of lymph nodes was assessed immunohistochemically in paraffin‐embedded tissue samples derived from 22 patients with oral cavity and oropharyngeal SCC. Results SCSs of lymph nodes harboring metastatic SCC contained significantly fewer CD169 + macrophages (106.5 ± 113.6 cells/mm 2 ) compared to nearby tumor‐free lymph nodes (321.3 ± 173.4 cells/mm 2 , P <. 001). This observation extended to 21 of the 22 cases investigated. In addition, 6 patients who later developed recurrent disease contained lower numbers of CD169 + cells (268.6 ± 169.5 cells/mm 2 ) in nearby tumor‐free lymph nodes compared to 341.0 ± 176.1 cells/mm 2 in those who remained disease free ( P =. 399). Human papillomavirus (HPV)–positive patients (n = 4) had a 6‐fold lower number of CD169 + cells in metastatic nodes (61.2 ± 85.5 cells/mm 2 ) compared to nearby tumor‐free lymph nodes (369.5 ± 175.5 cells/mm 2 , P =. 028). In comparison, HPV‐negative patients had only a 3‐fold reduction (116.6 ± 118.5 cells/mm 2 vs 310.6 ± 176.2 cells/mm 2 , P <. 001). Conclusion Metastatic spread of SCC to regional lymph nodes is associated with lower abundance of CD169 + macrophages in the SCSs of draining lymph nodes. These results set the stage for an in‐depth investigation into the mechanism(s) by which metastatic SCC controls CD169 + macrophage abundance and its significance as it relates to prognosis and treatment response.
18
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2016 · 16.2K citations · Full text
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
K. Kian Ang, Jonathan Harris, Richard Wheeler et al. · New England Journal of Medicine · 2010 · 6.5K citations · Full text
Kenichi Asano, Ami Nabeyama, Yasunobu Miyake et al. · Immunity · 2010 · 444 citations · Full text
Life Sciences, Immunology, Oncology +14
SCS macrophages suppress melanoma by restricting tumor-derived vesicle–B cell interactions
Ferdinando Pucci, Christopher Garris, Charles Pin‐Kuang Lai et al. · Science · 2016 · 346 citations · Full text
Medicine, Immunology, Oncology +17